Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.

Francisco J Gil-LópezJ MontoyaMercè FalipJ AparicioF J López-GonzálezR ToledanoA Gil-NagelA MolinsI GarcíaP SerranoG DomenechF TorresAntonio DonaireM Carreño

Published in: Acta neurologica Scandinavica (2018)

Perampanel caused clinically meaningful improvements in patients with drug-resistant myoclonic seizures. It was generally well tolerated, but psychiatric and neurological side effects sometimes required follow-up and dose reduction.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
mental health
open label
temporal lobe epilepsy
double blind
cerebral ischemia
placebo controlled
subarachnoid hemorrhage